Evidence map›Paper›PMID 37870718›Full record

ArticleJournal of neurovirology2025

Immune response to COVID-19 vaccines among people living with human T-cell lymphotropic virus type 1 infection: a retrospective cohort study from Iran.

Reza Jafarzadeh Esfehani, Zohreh Vahidi, Mohammad Shariati, Arman Mosavat, Azam Shafaei, Maryam Shahi, Houshang Rafatpanah, Hamid Reza Bidkhori, Reza Boostani, Mohammad Reza Hedayati-Moghaddam

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurovirology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Reza Jafarzadeh EsfehaniBlood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR), Razavi Khorasan Branch, Ferdowsi University Campus, Azadi-Square, Mashhad, 9177949367, Iran.
Zohreh VahidiImmunology Research Center, Inflammation and Inflammatory Diseases Division, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammad ShariatiStem Cells and Regenerative Medicine Research Department, Academic Center for Education, Culture, and Research (ACECR), Razavi Khorasan Branch, Mashhad, Iran.
Arman MosavatBlood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR), Razavi Khorasan Branch, Ferdowsi University Campus, Azadi-Square, Mashhad, 9177949367, Iran.
Azam ShafaeiBlood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR), Razavi Khorasan Branch, Ferdowsi University Campus, Azadi-Square, Mashhad, 9177949367, Iran.
Maryam ShahiBlood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR), Razavi Khorasan Branch, Ferdowsi University Campus, Azadi-Square, Mashhad, 9177949367, Iran.
Houshang RafatpanahImmunology Research Center, Inflammation and Inflammatory Diseases Division, Mashhad University of Medical Sciences, Mashhad, Iran.
Hamid Reza BidkhoriBlood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR), Razavi Khorasan Branch, Ferdowsi University Campus, Azadi-Square, Mashhad, 9177949367, Iran.
Reza BoostaniDepartment of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, 917699199, Iran. BoostaniR@mums.ac.ir.
Mohammad Reza Hedayati-MoghaddamBlood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR), Razavi Khorasan Branch, Ferdowsi University Campus, Azadi-Square, Mashhad, 9177949367, Iran. drhedayati@acecr.ac.ir.ORCID http://orcid.org/0000-0001-9133-5006
Academic Center for Education, Culture and Research · IRMashhad University of Medical Sciences · IR

Funding

Academic Center for Education, Culture and Research [ACECR 3101-20]
6 · The paper itself

Abstract

The effectiveness of COVID-19 vaccination is still unclear in individuals with underlying diseases such as HTLV-1 infection. This retrospective cohort study aimed to evaluate the humoral response of COVID-19 vaccines among people living with HTLV-1 (PLHTLV) in northeastern Iran. From December 2021 to October 2022, eighty-six HTLV-1

Indexed as

Antibodies, ViralCOVID-19COVID-19 VaccinesHTLV-I InfectionsAdultFemaleHumansHuman T-lymphotropic virus 1Immunity, HumoralIranMaleMiddle AgedRetrospective StudiesSARS-CoV-2Antibodies, ViralCOVID-19 VaccinesCOVID-19Human T lymphotropic virus type 1Humoral immunitySARS-CoV-2Vaccination

Identifiers

PMID37870718
OpenAlexW4387866258

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.